Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Option Care Health Inc(OPCH)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for OPCH
09/17/2026: OPCH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Option Care Health is a leading independent provider of home and alternate-site infusion services in the United States. The company has a stable business model, benefiting from the long-term healthcare trend of shifting care from hospitals to the home. Its primary strengths include a broad national network and established payer relationships, which support consistent revenue growth. Investors should monitor competitive risks from vertically integrated insurance firms and sensitivity to healthcare reimbursement policies. Option Care Health is generally suited for growth-oriented investors looking for exposure to secular healthcare trends, though the lack of a dividend means it is less appropriate for pure income-focused portfolios.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company operates in a growing sector benefiting from the shift toward home-based care. |
| Momentum investor | Strong fit while signal remains positive | The stock often tracks with positive industry sentiment and secular growth trends. |
| Value investor | Mixed fit | Valuation levels fluctuate based on growth expectations and integration success. |
| Dividend investor | Weak fit | The company does not pay a dividend, focusing all capital on reinvestment. |
| Low-risk investor | Mixed fit | Healthcare policy risks and reimbursement volatility contribute to moderate stock price sensitivity. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock can be sensitive to quarterly payer contract renewals and healthcare regulatory news. |
| Valuation risk | Medium | Investors must weigh the company's growth potential against current market multiples. |
| Competition risk (PBM integration) | High | Vertically integrated giants like CVS and Optum can influence network access. |
| Business quality | Medium / high | The company has built a solid operational framework but faces inherent complexity in clinical service delivery. |
| Dividend income | Low / none | No income component exists for investors seeking dividends. |
| Execution risk | Medium | Ongoing successful integration of acquisitions and management of clinical staffing are critical. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit 15.37% | Avg. Invested days 54 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 09/17/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.67B USD | Price to earnings Ratio 17.86 | 1Y Target Price 28.58 |
Price to earnings Ratio 17.86 | 1Y Target Price 28.58 | ||
Volume (30-day avg) 2.0M shares | Beta 0.61 | 52 Weeks Range 18.01 - 36.80 | Updated Date 09/17/2026 |
52 Weeks Range 18.01 - 36.80 | Updated Date 09/17/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.37 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Home Infusion Services | Provision of specialty drugs, supplies, and clinical nursing oversight in patient homes. | The company earns money by providing complex medication delivery and clinical support services that save insurers money compared to hospital stays. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE 17.86 | Forward PE 11.31 | Enterprise Value 4.60B | Price to Sales(TTM) 0.64 |
Enterprise Value 4.60B | Price to Sales(TTM) 0.64 | ||
Enterprise Value to Revenue 0.81 | Enterprise Value to EBITDA 11.18 | Shares Outstanding 149.79M | Shares Floating 147.71M |
Shares Outstanding 149.79M | Shares Floating 147.71M | ||
Percent Insiders 1.28 | Percent Institutions 108.84 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Option Care Health Inc
Exchange NASDAQ | Headquarters Bannockburn, IL, United States | ||
IPO Launch date 1996-08-15 | CEO, President & Director Mr. John Charles Rademacher | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 8000 | Website https://optioncarehealth.com |
Full time employees 8000 | Website https://optioncarehealth.com | ||
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.